Natural Killer T Cells Are Involved in Adipose Tissues Inflammation and Glucose Intolerance in Diet-Induced Obese Mice

BACKGROUND—Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissu...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 30; no. 2; pp. 193 - 199
Main Authors Ohmura, Kazue, Ishimori, Naoki, Ohmura, Yoshinori, Tokuhara, Satoshi, Nozawa, Atsushi, Horii, Shunpei, Andoh, Yasuhiro, Fujii, Satoshi, Iwabuchi, Kazuya, Onoé, Kazunori, Tsutsui, Hiroyuki
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.02.2010
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND—Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue. OBJECTIVE—To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. METHODS AND RESULTS—Male β2-microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, α-galactosylceramide, 0.1 μg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. α-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue. CONCLUSION—NKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity.
AbstractList BACKGROUNDMacrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue.OBJECTIVETo determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice.METHODS AND RESULTSMale beta(2)-microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks [corrected]. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, alpha-galactosylceramide, 0.1 microg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. alpha-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue.CONCLUSIONSNKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity.
Background— Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue. Objective— To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. Methods and Results— To determine whether NKT cells are involved in the development of glucose intolerance, male β 2 -microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, α-galactosylceramide, 0.1 μg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. α-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue. Conclusion— NKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity. Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of glucose intolerance in obesity. Natural killer T cells, which integrate proinflammatory cytokines, are present in adipose tissue. They are involved in the development of adipose tissue inflammation and glucose intolerance in diet-induced obese mice.
BACKGROUND—Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue. OBJECTIVE—To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. METHODS AND RESULTS—Male β2-microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, α-galactosylceramide, 0.1 μg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. α-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue. CONCLUSION—NKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity.
Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue. To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. Male beta(2)-microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks [corrected]. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, alpha-galactosylceramide, 0.1 microg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. alpha-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue. NKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity.
Author Fujii, Satoshi
Ohmura, Kazue
Iwabuchi, Kazuya
Horii, Shunpei
Tsutsui, Hiroyuki
Tokuhara, Satoshi
Onoé, Kazunori
Nozawa, Atsushi
Ohmura, Yoshinori
Andoh, Yasuhiro
Ishimori, Naoki
AuthorAffiliation From the Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K.O., N.I., Y.O., S.T., A.N., S.H., Y.A., and H.T.); the Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya, Japan (S.F.); Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan (K.I. and K.O.)
AuthorAffiliation_xml – name: From the Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K.O., N.I., Y.O., S.T., A.N., S.H., Y.A., and H.T.); the Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya, Japan (S.F.); Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan (K.I. and K.O.)
Author_xml – sequence: 1
  givenname: Kazue
  surname: Ohmura
  fullname: Ohmura, Kazue
  organization: From the Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K.O., N.I., Y.O., S.T., A.N., S.H., Y.A., and H.T.); the Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya, Japan (S.F.); Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan (K.I. and K.O.)
– sequence: 2
  givenname: Naoki
  surname: Ishimori
  fullname: Ishimori, Naoki
– sequence: 3
  givenname: Yoshinori
  surname: Ohmura
  fullname: Ohmura, Yoshinori
– sequence: 4
  givenname: Satoshi
  surname: Tokuhara
  fullname: Tokuhara, Satoshi
– sequence: 5
  givenname: Atsushi
  surname: Nozawa
  fullname: Nozawa, Atsushi
– sequence: 6
  givenname: Shunpei
  surname: Horii
  fullname: Horii, Shunpei
– sequence: 7
  givenname: Yasuhiro
  surname: Andoh
  fullname: Andoh, Yasuhiro
– sequence: 8
  givenname: Satoshi
  surname: Fujii
  fullname: Fujii, Satoshi
– sequence: 9
  givenname: Kazuya
  surname: Iwabuchi
  fullname: Iwabuchi, Kazuya
– sequence: 10
  givenname: Kazunori
  surname: Onoé
  fullname: Onoé, Kazunori
– sequence: 11
  givenname: Hiroyuki
  surname: Tsutsui
  fullname: Tsutsui, Hiroyuki
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22327131$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19910631$$D View this record in MEDLINE/PubMed
BookMark eNpFkUtv1DAURi1URB_wB1ggbxCrDH4nWYYpbUcUuhnYRo59oxocZ7CTqfj3OJ0IFpZ95XM_XR9forMwBkDoLSUbShX92Ox_fGrumg0l9YbWlaLiBbqgkolCKK7O8pmUdSGVYOfoMqWfhBDBGHmFzmldU6I4vUDHb3qao_b4i_MeIt7jLXifcBMB78Jx9Eew2AXcWHcYE-C9S2mGlO96r4dBT24MWAeLb_1sFmAXpjEH6WBg6bt2MBW7YGeTcx46yMRXZ-A1etlrn-DNul-h7zef99u74v7hdrdt7gsjRcmLmhPbl1pUlSG9NVSWrBeSG91ZaYxQpuq1rjpZCwuKdErTToIuqdWik6oU_Ap9OOUe4vg7zz21g0smv1AHGOfUlpxnbYSXmWQn0sQxpQh9e4hu0PFPS0m76G5X3bmu25Pu3PRujZ-7Aez_ltVvBt6vgE5G-37x4tI_jjHOSvrMiRP3NPoJYvrl5yeI7SNoPz22y8dxRWTBCCWE5bLIi3L-F3wwmhU
CODEN ATVBFA
CitedBy_id crossref_primary_10_1172_JCI62739
crossref_primary_10_1007_s00018_013_1414_1
crossref_primary_10_1371_journal_pone_0025478
crossref_primary_10_1080_10408398_2014_883356
crossref_primary_10_1038_s41577_018_0034_2
crossref_primary_10_1146_annurev_immunol_031210_101322
crossref_primary_10_1186_1476_511X_10_198
crossref_primary_10_1161_ATVBAHA_112_301105
crossref_primary_10_1038_icb_2011_110
crossref_primary_10_1111_j_1600_065X_2012_01151_x
crossref_primary_10_3945_jn_114_200758
crossref_primary_10_1016_j_jri_2011_01_008
crossref_primary_10_1080_10408398_2020_1775546
crossref_primary_10_1161_ATVBAHA_109_201616
crossref_primary_10_1016_j_it_2012_08_009
crossref_primary_10_1007_s12026_011_8261_7
crossref_primary_10_2217_imt_11_117
crossref_primary_10_1016_j_bbalip_2019_04_016
crossref_primary_10_1007_s13410_016_0531_4
crossref_primary_10_1016_j_intimp_2019_105948
crossref_primary_10_2337_db14_0272
crossref_primary_10_1016_j_diabet_2011_03_002
crossref_primary_10_1073_pnas_1200498109
crossref_primary_10_3389_fimmu_2018_01616
crossref_primary_10_1002_oby_20341
crossref_primary_10_1161_CIRCRESAHA_112_270132
crossref_primary_10_1002_dmrr_1272
crossref_primary_10_2337_db12_1404
crossref_primary_10_1074_jbc_M112_350066
crossref_primary_10_1186_1471_2407_14_949
crossref_primary_10_1371_journal_pone_0011861
crossref_primary_10_1038_nrendo_2012_114
crossref_primary_10_1038_icb_2013_112
crossref_primary_10_1152_ajpendo_00447_2011
crossref_primary_10_1097_MCO_0b013e32833aab7f
crossref_primary_10_3390_ijms23031640
crossref_primary_10_1016_j_smim_2012_12_001
crossref_primary_10_4049_jimmunol_2100313
crossref_primary_10_3389_fragi_2021_803482
crossref_primary_10_1016_S1957_2557_15_30075_4
crossref_primary_10_1371_journal_pone_0030568
crossref_primary_10_3389_fpsyt_2017_00221
crossref_primary_10_4252_wjsc_v11_i3_147
crossref_primary_10_3390_nu9121289
crossref_primary_10_1161_CIRCRESAHA_119_315896
crossref_primary_10_1253_circj_CJ_11_1184
crossref_primary_10_1007_s00281_013_0403_7
crossref_primary_10_1194_jlr_M041020
crossref_primary_10_3389_fimmu_2018_00314
crossref_primary_10_1042_BJ20111708
crossref_primary_10_1051_jbio_2017008
crossref_primary_10_1016_j_smim_2015_10_006
crossref_primary_10_4049_jimmunol_1800556
crossref_primary_10_3389_fimmu_2018_02730
crossref_primary_10_1111_imm_12269
crossref_primary_10_1016_j_jhep_2013_08_008
crossref_primary_10_2217_clp_14_50
crossref_primary_10_1016_j_bj_2015_04_001
crossref_primary_10_4161_adip_24881
crossref_primary_10_1074_jbc_M114_551242
crossref_primary_10_3389_fimmu_2019_00082
crossref_primary_10_3389_fimmu_2023_1175147
crossref_primary_10_4093_dmj_2017_41_4_229
crossref_primary_10_1538_expanim_62_319
crossref_primary_10_1189_jlb_0210072
crossref_primary_10_1152_ajpendo_00514_2012
crossref_primary_10_3390_biomedicines11051290
crossref_primary_10_1016_j_tem_2012_05_011
crossref_primary_10_2337_db12_1076
crossref_primary_10_1016_j_humimm_2013_11_004
crossref_primary_10_3390_nu13082830
crossref_primary_10_1371_journal_pone_0039553
crossref_primary_10_1051_medsci_20112711016
crossref_primary_10_1007_s10616_017_0157_5
crossref_primary_10_3390_immuno4010006
crossref_primary_10_1002_eji_201545502
crossref_primary_10_1016_j_immuni_2012_06_016
crossref_primary_10_2337_db11_1373
crossref_primary_10_1016_j_cmet_2013_05_008
crossref_primary_10_1161_ATVBAHA_111_241869
crossref_primary_10_1016_j_immuni_2016_08_002
crossref_primary_10_4161_adip_22296
crossref_primary_10_1016_j_cyto_2014_02_011
crossref_primary_10_1016_j_molmet_2016_05_016
crossref_primary_10_1097_MD_0000000000034999
crossref_primary_10_3389_fendo_2019_00137
crossref_primary_10_1038_ijo_2015_21
crossref_primary_10_1111_j_1600_065X_2012_01142_x
crossref_primary_10_1586_erc_11_43
crossref_primary_10_1016_j_orcp_2015_10_012
crossref_primary_10_3390_ijms160817469
crossref_primary_10_1007_s00125_012_2607_0
crossref_primary_10_1002_oby_20159
crossref_primary_10_1371_journal_pone_0019831
crossref_primary_10_1111_obr_12335
crossref_primary_10_3390_ijms222212451
crossref_primary_10_1093_eurheartj_eht099
crossref_primary_10_1586_eci_11_18
crossref_primary_10_1016_j_cyto_2013_02_009
crossref_primary_10_3945_jn_114_205443
crossref_primary_10_1371_journal_pone_0114790
crossref_primary_10_1161_CIRCRESAHA_110_225698
crossref_primary_10_3389_fcell_2022_803280
crossref_primary_10_3390_nu14214692
crossref_primary_10_1016_j_it_2019_07_006
crossref_primary_10_1080_21623945_2016_1241913
crossref_primary_10_1016_j_cyto_2013_09_009
crossref_primary_10_1186_s40364_020_00257_6
crossref_primary_10_1016_j_jss_2024_03_037
crossref_primary_10_1016_j_mam_2012_10_002
crossref_primary_10_1097_MOL_0b013e3283393867
crossref_primary_10_3109_07853890_2012_705015
crossref_primary_10_1016_j_mam_2012_10_003
crossref_primary_10_4061_2011_529061
crossref_primary_10_1016_j_cellimm_2017_03_001
crossref_primary_10_1371_journal_pone_0025017
crossref_primary_10_1016_j_vph_2012_09_002
crossref_primary_10_3349_ymj_2018_59_4_554
crossref_primary_10_1016_j_smim_2011_11_011
crossref_primary_10_3389_fimmu_2018_01969
crossref_primary_10_1016_j_bbadis_2013_05_017
crossref_primary_10_1155_2015_401630
crossref_primary_10_1038_s41423_021_00804_7
crossref_primary_10_1128_MCB_00552_12
crossref_primary_10_1194_jlr_M011338
crossref_primary_10_1002_stem_2016
crossref_primary_10_1097_QAI_0000000000001573
crossref_primary_10_1007_s12020_023_03521_5
crossref_primary_10_1016_j_smim_2016_09_005
crossref_primary_10_1016_j_idairyj_2011_02_001
crossref_primary_10_1016_j_it_2011_04_008
crossref_primary_10_1515_hmbci_2018_0012
crossref_primary_10_1007_s11154_013_9274_4
crossref_primary_10_1007_s11481_013_9469_1
crossref_primary_10_1186_1476_511X_11_21
crossref_primary_10_1210_en_2014_1794
crossref_primary_10_1530_JOE_14_0283
crossref_primary_10_2337_db12_1275
crossref_primary_10_2337_db12_0222
crossref_primary_10_4161_adip_26220
crossref_primary_10_1210_en_2011_2006
crossref_primary_10_1016_j_cmet_2013_02_019
crossref_primary_10_1016_j_ejphar_2017_03_052
crossref_primary_10_1007_s00125_013_2869_1
crossref_primary_10_1016_j_bbmt_2016_03_016
crossref_primary_10_3389_fimmu_2018_01314
crossref_primary_10_1155_2013_136584
crossref_primary_10_3389_fcvm_2021_659418
crossref_primary_10_1111_sji_12747
crossref_primary_10_1172_JCI57132
Cites_doi 10.1084/jem.20030997
10.1038/nri1309
10.1007/s00125-006-0572-1
10.1038/nature05485
10.1016/j.imlet.2005.06.010
10.1038/nri1531
10.1111/j.1365-3083.2007.02062.x
10.1172/JCI200319246
10.1016/j.jhep.2003.10.017
10.1161/circulationaha.106.638379
10.1172/JCI29881
10.1172/JCI36150
10.1002/path.1869
10.1172/JCI20514
10.1124/mol.107.040782
10.1161/circresaha.108.177105
10.1172/JCI25102
10.1016/j.febslet.2005.05.031
10.1126/science.2112266
10.1074/jbc.M212307200
10.1038/nm.1964
10.1016/S0167-5699(00)01735-7
10.1172/JCI24335
10.1016/j.lfs.2006.09.034
10.1016/j.coi.2007.03.001
10.1056/NEJM199901143400207
10.1038/39335
10.1182/blood-2003-10-3485
10.1097/01.tp.0000250573.50046.89
ContentType Journal Article
Copyright 2010 American Heart Association, Inc.
2015 INIST-CNRS
Copyright_xml – notice: 2010 American Heart Association, Inc.
– notice: 2015 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/ATVBAHA.109.198614
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 199
ExternalDocumentID 10_1161_ATVBAHA_109_198614
19910631
22327131
00043605-201002000-00013
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.Z2
01R
08R
0R
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
ABBUW
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACGOD
ACPRK
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
C1A
C45
CS3
DIK
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FRP
FW0
GJ
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
N9A
N~7
N~B
N~M
O0-
O9-
OAG
OAH
OB2
OCUKA
ODA
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
PZZ
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
X7M
Z2
ZA5
ZGI
---
.3C
.55
.GJ
0R~
AAGIX
AAHPQ
AAQKA
AASOK
AAUGY
ABASU
ABDIG
ABQRW
ACCJW
ACILI
ADGGA
AE6
AEETU
AFDTB
AGINI
AHJKT
AHOMT
AHRYX
AJNWD
AKALU
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
BS7
DIWNM
EEVPB
FCALG
GNXGY
GQDEL
HZ~
IKREB
IPNFZ
IQODW
OJAPA
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
ZZMQN
AAAAV
AAIQE
AASCR
ABJNI
ABVCZ
ACLDA
ACXJB
ADHPY
AHQNM
AINUH
AJZMW
BQLVK
CGR
CUY
CVF
ECM
EIF
ERAAH
HLJTE
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c5473-930df7a488c0fdc1572f453cabd5cc46c8faa8b594de60b6a1b5ea71da4b56743
ISSN 1079-5642
IngestDate Sat Oct 26 00:06:14 EDT 2024
Fri Aug 23 00:17:35 EDT 2024
Tue Oct 15 23:41:25 EDT 2024
Sun Oct 22 16:03:46 EDT 2023
Thu Aug 13 19:50:12 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Endocrinopathy
Obesity
visceral adipose tissues
Adipose tissue
Rodentia
Nutrition disorder
glucose intolerance
Cardiovascular disease
Inflammation
natural killer T cells
Vascular disease
Natural killer cell
Vertebrata
macrophages
Mammalia
Mouse
Animal
Atherosclerosis
Impaired glucose tolerance
Nutritional status
Macrophage
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5473-930df7a488c0fdc1572f453cabd5cc46c8faa8b594de60b6a1b5ea71da4b56743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1161/atvbaha.109.198614
PMID 19910631
PQID 733614037
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_733614037
crossref_primary_10_1161_ATVBAHA_109_198614
pubmed_primary_19910631
pascalfrancis_primary_22327131
wolterskluwer_health_00043605-201002000-00013
ProviderPackageCode L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
OB2
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 2000
PublicationDate 2010-February
PublicationDateYYYYMMDD 2010-02-01
PublicationDate_xml – month: 02
  year: 2010
  text: 2010-February
PublicationDecade 2010
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 2010
Publisher American Heart Association, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott Williams & Wilkins
References Arterioscler Thromb Vasc Biol.2010 Sep;30(9):e169
e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_11_2
e_1_3_3_10_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_1_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_9_2
  doi: 10.1084/jem.20030997
– ident: e_1_3_3_16_2
  doi: 10.1038/nri1309
– ident: e_1_3_3_25_2
  doi: 10.1007/s00125-006-0572-1
– ident: e_1_3_3_1_2
  doi: 10.1038/nature05485
– ident: e_1_3_3_28_2
  doi: 10.1016/j.imlet.2005.06.010
– ident: e_1_3_3_11_2
  doi: 10.1038/nri1531
– ident: e_1_3_3_24_2
  doi: 10.1111/j.1365-3083.2007.02062.x
– ident: e_1_3_3_2_2
  doi: 10.1172/JCI200319246
– ident: e_1_3_3_20_2
  doi: 10.1016/j.jhep.2003.10.017
– ident: e_1_3_3_4_2
  doi: 10.1161/circulationaha.106.638379
– ident: e_1_3_3_17_2
  doi: 10.1172/JCI29881
– ident: e_1_3_3_18_2
  doi: 10.1172/JCI36150
– ident: e_1_3_3_13_2
  doi: 10.1002/path.1869
– ident: e_1_3_3_12_2
  doi: 10.1172/JCI20514
– ident: e_1_3_3_22_2
  doi: 10.1124/mol.107.040782
– ident: e_1_3_3_5_2
  doi: 10.1161/circresaha.108.177105
– ident: e_1_3_3_27_2
  doi: 10.1172/JCI25102
– ident: e_1_3_3_7_2
  doi: 10.1016/j.febslet.2005.05.031
– ident: e_1_3_3_15_2
  doi: 10.1126/science.2112266
– ident: e_1_3_3_23_2
  doi: 10.1074/jbc.M212307200
– ident: e_1_3_3_14_2
  doi: 10.1038/nm.1964
– ident: e_1_3_3_29_2
  doi: 10.1016/S0167-5699(00)01735-7
– ident: e_1_3_3_3_2
  doi: 10.1172/JCI24335
– ident: e_1_3_3_21_2
  doi: 10.1016/j.lfs.2006.09.034
– ident: e_1_3_3_6_2
  doi: 10.1016/j.coi.2007.03.001
– ident: e_1_3_3_8_2
  doi: 10.1056/NEJM199901143400207
– ident: e_1_3_3_26_2
  doi: 10.1038/39335
– ident: e_1_3_3_10_2
  doi: 10.1182/blood-2003-10-3485
– ident: e_1_3_3_19_2
  doi: 10.1097/01.tp.0000250573.50046.89
SSID ssj0004220
Score 2.467929
Snippet BACKGROUND—Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer...
Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT)...
Background— Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer...
BACKGROUNDMacrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 193
SubjectTerms Animals
Atherosclerosis (general aspects, experimental research)
beta 2-Microglobulin - deficiency
beta 2-Microglobulin - genetics
Biological and medical sciences
Blood and lymphatic vessels
Blood vessels and receptors
Cardiology. Vascular system
Cytokines - genetics
Dietary Fats
Disease Models, Animal
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Fundamental and applied biological sciences. Psychology
Galactosylceramides - pharmacology
Gene Expression Regulation
Glucose Intolerance - immunology
Glucose Intolerance - physiopathology
Inflammation - immunology
Inflammation - physiopathology
Intra-Abdominal Fat - drug effects
Intra-Abdominal Fat - immunology
Intra-Abdominal Fat - physiopathology
Lymphocyte Activation - drug effects
Macrophages - immunology
Male
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Knockout
Natural Killer T-Cells - drug effects
Natural Killer T-Cells - immunology
Obesity - complications
Obesity - immunology
Obesity - physiopathology
RNA, Messenger - metabolism
Time Factors
Vertebrates: cardiovascular system
Title Natural Killer T Cells Are Involved in Adipose Tissues Inflammation and Glucose Intolerance in Diet-Induced Obese Mice
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-201002000-00013
https://www.ncbi.nlm.nih.gov/pubmed/19910631
https://search.proquest.com/docview/733614037
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahgzEYo7tn3Yoe9haUxdfEj153yVYaGLijezKSJVOT1A6J3UF_7X7KzpHkxFk6WPdiElvy7XyWdKTvfIeQt1GOomJKMl95IfO5A9-c8nIm_SBCmwdCp044m4XTc__rRXDR6_3qsJaaWgyzm1vjSv7HqrAP7IpRsnew7OaksAN-g31hCxaG7T_ZeMaNasapDugbJIMTtVisB_EKCZHQ7lwrqeczZLFEWnqiX_IajuWAAxOzqBcPPlve-peyruBEOooA6n0oVM0wtwdyBDCDgEKW_Q53KEZGaFGt4caguzV6BZh54Uq0__D8G7qrlXzazOxeXjUrG5N206gtTC8BQSYEfsarebFf_keFU2dQZjtLPm9Qe9rMctd4uDuhgWvxu-SQdqVqCp963UXpHjsUXNeIBaGR5xoq24K7PkMVtG4Tb5d-io6nbdprx6RntF2_Y3I17fcqIfYqcfL9fTyNUYBr6EST0AS__qHWrZdWwUVk-GSjNm4f0yrfc6EpRNLh6beOnr3rGr0M-yBtWFfovNu_3M7Q6eESTMcXuUm_cpt_BGV-Vki5WM91xEVn3JQckkfW4aGxQe9j0lPlE3L_zFI6npJrC2JqQEwTqkEMFRRtQUyLkloQUwti2gUxBZBRC2LaATHW64KYahBTBPEzcv7pY3IyZTYZCMswPTaLvJHMxxz6m2yUy8wJxm7uB17GhQyyzA-zSc75RASRL1U4EiF3RKD42JHcFwFG2jwnB2VVqpeEejAgg2Fz7gkpfJ_nXLpCRgoaKj7JQmfSJ4P2PadLo_mSal85dFJrFSRupMYqfXK8Y4pNFRh4u3ihPqGtbVJou3FBjpeqatYpSpGiXua4T14Ym22vB34beA9Qme0YMTXh0enfcPbqjuWPyIPtN_iaHNSrRr2BYXYtjjVSfwOt9M8E
link.rule.ids 315,783,787,27938,27939
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Natural+Killer+T+Cells+Are+Involved+in+Adipose+Tissues+Inflammation+and+Glucose+Intolerance+in+Diet-Induced+Obese+Mice&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Ohmura%2C+Kazue&rft.au=Ishimori%2C+Naoki&rft.au=Ohmura%2C+Yoshinori&rft.au=Tokuhara%2C+Satoshi&rft.date=2010-02-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=1079-5642&rft.eissn=1524-4636&rft.volume=30&rft.issue=2&rft.spage=193&rft.epage=199&rft_id=info:doi/10.1161%2FATVBAHA.109.198614&rft.externalDocID=00043605-201002000-00013
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon